Factores de riesgo asociados a pacientes con encefalopatía hepática según su grado de presentación
Fecha
2020
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Carrera de Medicina
Resumen
Introducción: La encefalopatía hepática (EH) es un síndrome neuropsiquiátrico complejo y potencialmente reversible que se presenta en pacientes con enfermedad hepática crónica avanzada o pacientes con grandes derivaciones portosistémicas o colaterales e insuficiencia hepática fulminante. De acuerdo al grado de presentación de la encefalopatía hepática, se pueden identificar cuatro estadios, I, II, III y IV en el cual abordaremos los factores de riesgo de cada uno de estos estadios
Objetivo: Determinar los factores de riesgo de la encefalopatía hepática según su grado de presentación.
Metodología: Se realizó un estudio descriptivo, observacional, de corte transversal y de enfoque cuantitativo, dirigido a determinar los factores de riesgo de la encefalopatía hepática según su grado de presentación en el Hospital General Liborio Panchana Sotomayor en el período de enero del 2017 a enero del 2020
Resultados: En la presente investigación se determina que la prevalencia de la encefalopatía hepática en pacientes con cirrosis hepática es del 35%, el 30,58% de los individuos en estadio I, un 14,88% posee HDA, mientras que un 11,57% alcalosis metabólica y un 4,13% hipopotasemia. De igual manera dentro de los 31,40% de pacientes en estadio III, un 20,66% posee HDA, mientras que un 9,09% alcalosis metabólica y un 1,65% hipopotasemia. Dentro del 29,76% de individuos con EH que se encuentra en estadio II, se puede identificar que un 12,40% presentó HDA y alcalosis metabólica. Finalmente, dentro del 8,27% de pacientes con EH en estadio IV, un 7,44% presentó problemas relacionados con la hemorragia digestiva alta y un 0,83% alcalosis metabólica
Conclusión: Dentro de los principales factores de riesgo asociados al desarrollo de encefalopatía hepática se encuentran la hemorragia digestiva alta, la edad y el sexo masculino.
Introduction: Hepatic encephalopathy (HE) is a complex and potentially reversible neuropsychiatric syndrome that occurs in patients with advanced chronic liver disease and / or patients with large portosystemic or collateral shunts and fulminant liver failure. According to the degree of presentation of hepatic encephalopathy, four stages can be identified, I, II, III and IV in which we will address the risk factors of each of these stages Objective: To determine the risk factors for hepatic encephalopathy according to its degree of presentation. Methodology: A descriptive, observational, cross-sectional study with a quantitative approach was carried out, aimed at determining the risk factors for hepatic encephalopathy according to their degree of presentation at the Liborio Panchana Sotomayor General Hospital in the period from January 2017 to January 2020. Results: In the present investigation it is determined that the prevalence of hepatic encephalopathy in patients with liver cirrhosis is 35%, 30.58% of stage I individuals, 14.88% have HDA, while 11, 57% metabolic alkalosis and 4.13% hypokalemia. Similarly, within the 31.40% of patients in stage III, 20.66% have HDA, while 9.09% have metabolic alkalosis and 1.65% hypokalemia. Among the 29.76% of individuals with HE who is in stage II, it can be identified that 12.40% presented HDA and metabolic alkalosis. Finally, among 8.27% of patients with stage IV HE, 7.44% presented problems related to upper gastrointestinal bleeding and 0.83% metabolic alkalosis. Conclusion: Among the main risk factors associated with the development of hepatic encephalopathy are upper gastrointestinal bleeding, age and male sex.
Introduction: Hepatic encephalopathy (HE) is a complex and potentially reversible neuropsychiatric syndrome that occurs in patients with advanced chronic liver disease and / or patients with large portosystemic or collateral shunts and fulminant liver failure. According to the degree of presentation of hepatic encephalopathy, four stages can be identified, I, II, III and IV in which we will address the risk factors of each of these stages Objective: To determine the risk factors for hepatic encephalopathy according to its degree of presentation. Methodology: A descriptive, observational, cross-sectional study with a quantitative approach was carried out, aimed at determining the risk factors for hepatic encephalopathy according to their degree of presentation at the Liborio Panchana Sotomayor General Hospital in the period from January 2017 to January 2020. Results: In the present investigation it is determined that the prevalence of hepatic encephalopathy in patients with liver cirrhosis is 35%, 30.58% of stage I individuals, 14.88% have HDA, while 11, 57% metabolic alkalosis and 4.13% hypokalemia. Similarly, within the 31.40% of patients in stage III, 20.66% have HDA, while 9.09% have metabolic alkalosis and 1.65% hypokalemia. Among the 29.76% of individuals with HE who is in stage II, it can be identified that 12.40% presented HDA and metabolic alkalosis. Finally, among 8.27% of patients with stage IV HE, 7.44% presented problems related to upper gastrointestinal bleeding and 0.83% metabolic alkalosis. Conclusion: Among the main risk factors associated with the development of hepatic encephalopathy are upper gastrointestinal bleeding, age and male sex.
Descripción
PDF
Palabras clave
ENCEFALOPATIA HEPATICA, FACTORES DE RIESGO, GRADO DE PRESENTACION, HOSPITAL GENERAL DR. LIBORIO PANCHANA SOTOMAYOR, CANTON SANTA ELENA, ECUADOR, EPIDEMIOLOGIA DESCRIPTIVA